May 14-18, 2024 | Orlando, FL |
This conference is designed for physicians, nursing professionals, physical therapists, researchers, scientists, podiatrists, and dietitians across all practice settings involved in wound healing or wound care issues. SAWC Spring provides attendees who study and treat wounds with state-of-the-art reviews of clinical problems and research information.
This educational conference will occur from May 14-18, 2024 at the Marriott World Center in Orlando, FL.
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 60 days of the live meeting will receive immediate documentation of credit. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
For questions regarding this activity, please email firstname.lastname@example.org
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Provided by HMP Education, an HMP Global Company.
For questions regarding this educational activity, please call 609-371-1137 or email email@example.com.
HMP Education designates the live activity SAWC General Session (general sessions and concurrent sessions) for a maximum of 24.25 AMA PRA Category 1 Credits™.
HMP Education designates each live activity, Industry-Supported Symposium, for a maximum of 1 AMA PRA Category 1 Credit™.
HMP Education designates each live activity, SAWC Pre-Conference, for a maximum of 4 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria.
SAWC General Session (general sessions and concurrent sessions) is designated for 24.25 AAPA Category 1 credits.
Each Industry-Supported Symposium is designated for 1 AAPA Category 1 credit.
Each SAWC Pre-Conference is designated for 4 AAPA Category 1 credits.
PAs should only claim credit commensurate with the extent of their participation.
The continuing nursing education live activity, SAWC General Session (general sessions, concurrent sessions), awards 24.25 contact hours.
Each Industry-Supported Symposium is designated for 1 contact hour.
Each continuing nursing education live activity, SAWC Pre-Conference, awards 4 contact hours.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this live activity for a maximum of 24.25 continuing education contact hours.
HMP Education has approved each Industry-Supported Symposium activity for a maximum of 1 continuing education contact hour.
HMP Education has approved each live activity, SAWC Pre-Conference, for a maximum of 4 continuing education contact hours.
HMP Education will be applying for pre-approval accreditation in California, Florida, Nevada, and Texas. If you practice in any other state, please consult its PT Board.
**Maximum credit hours are subject to change pending final agenda.
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please call 609-371-1137.
These are promotional programs and no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
Applications for commercial support from health care related industries are pending. Commercial support will be acknowledged as it is received.
Note: Information contained herein is subject to change without notice.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at firstname.lastname@example.org or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.